158 related articles for article (PubMed ID: 7962045)
1. Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer.
Chen CA; Chen TM; Wu CC; Chang CF; Hsieh CY
J Cancer Res Clin Oncol; 1994; 120(11):678-82. PubMed ID: 7962045
[TBL] [Abstract][Full Text] [Related]
2. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus.
Jiko K; Tsuda H; Sato S; Hirohashi S
Int J Cancer; 1994 Dec; 59(5):601-6. PubMed ID: 7960232
[TBL] [Abstract][Full Text] [Related]
3. Type of human papillomavirus and expression of p53 in elderly women with cervical cancer.
Saito J; Hoshiai H; Noda K
Gynecol Obstet Invest; 2000; 49(3):190-3. PubMed ID: 10729761
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
5. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
Nakagawa S; Yoshikawa H; Jimbo H; Onda T; Yasugi T; Matsumoto K; Kino N; Kawana K; Kozuka T; Nakagawa K; Aoki M; Taketani Y
Br J Cancer; 1999 Mar; 79(7-8):1139-44. PubMed ID: 10098748
[TBL] [Abstract][Full Text] [Related]
6. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP
Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371
[TBL] [Abstract][Full Text] [Related]
7. The role of p53 inactivation in human cervical cell carcinoma development.
Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
[TBL] [Abstract][Full Text] [Related]
8. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
9. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing.
Andersson S; Rylander E; Larson B; Sigurdardottir S; Backlund I; Sällström J; Wilander E
Oncol Rep; 2003; 10(1):175-9. PubMed ID: 12469166
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up.
Hernádi Z; Szarka K; Sápy T; Krasznai Z; Veress G; Póka R
BJOG; 2003 Feb; 110(2):205-9. PubMed ID: 12618167
[TBL] [Abstract][Full Text] [Related]
11. Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers.
Lo KW; Cheung TH; Chung TK; Wang VW; Poon JS; Li JC; Lam P; Wong YF
Gynecol Obstet Invest; 2001; 51(3):202-7. PubMed ID: 11306910
[TBL] [Abstract][Full Text] [Related]
12. Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa.
Astori G; Merluzzi S; Arzese A; Brosolo P; de Pretis G; Maieron R; Pipan C; Botta GA
Digestion; 2001; 64(1):9-14. PubMed ID: 11549832
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.
Kessis TD; Slebos RJ; Han SM; Shah K; Bosch XF; Muñoz N; Hedrick L; Cho KR
Am J Pathol; 1993 Nov; 143(5):1398-405. PubMed ID: 8238255
[TBL] [Abstract][Full Text] [Related]
14. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
[TBL] [Abstract][Full Text] [Related]
15. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
Int J Gynecol Cancer; 2001; 11(1):39-48. PubMed ID: 11285032
[TBL] [Abstract][Full Text] [Related]
16. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.
Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H
Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563
[TBL] [Abstract][Full Text] [Related]
17. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
Milde-Langosch K; Albrecht K; Joram S; Schlechte H; Giessing M; Löning T
Int J Cancer; 1995 Nov; 63(5):639-45. PubMed ID: 7591279
[TBL] [Abstract][Full Text] [Related]
18. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix.
Tenti P; Pavanello S; Padovan L; Spinillo A; Vesentini N; Zappatore R; Migliora P; Zara C; Ranzani GN; Carnevali L
Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of microsatellite instability in patients with cervical carcinomas.
Rodriguez JA; Barros F; Carracedo A; Mugica-van Herckenrode CM
Diagn Mol Pathol; 1998 Oct; 7(5):276-82. PubMed ID: 9990486
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma.
Kim JW; Cho YH; Lee CG; Kim JH; Kim HK; Kim EJ; Han KT; Namkoong SE
Acta Oncol; 1997; 36(3):295-300. PubMed ID: 9208900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
